P. Comella
Division of Medical Oncology A
National Tumor Institute
Naples
Italy
Name/email consistency: high
- Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients. Comella, P., Casaretti, R., Crucitta, E., De Vita, F., Palmeri, S., Avallone, A., Orditura, M., De Lucia, L., Del Prete, S., Catalano, G., Lorusso, V., Comella, G. Br. J. Cancer (2002)
- Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group. Comella, P., Crucitta, E., De Vita, F., De Lucia, L., Farris, A., Del Gaizo, F., Palmeri, S., Lannelli, A., Mancarella, S., Tafuto, S., Maiorino, L., Buzzi, F., De Cataldis, G. Ann. Oncol. (2002)
- Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies. Comella, P., Casaretti, R., De Rosa, V., Avallone, A., Izzo, F., Fiore, F., Lapenta, L., Comella, G. Ann. Oncol. (2002)
- Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group. Comella, P., Biglietto, M., Casaretti, R., De Lucia, L., Avallone, A., Maiorino, L., Di Lullo, L., De Cataldis, G., Rivellini, F., Comella, G. Oncology (2001)
- Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group. Comella, P., Frasci, G., Panza, N., Manzione, L., De Cataldis, G., Cioffi, R., Maiorino, L., Micillo, E., Lorusso, V., Di Rienzo, G., Filippelli, G., Lamberti, A., Natale, M., Bilancia, D., Nicolella, G., Di Nota, A., Comella, G. J. Clin. Oncol. (2000)
- Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group. Comella, P., De Vita, F., De Lucia, L., Casaretti, R., Avallone, A., Orditura, M., Rivellini, F., Palmeri, S., Catalano, G., Comella, G. Ann. Oncol. (2000)
- Interim analysis of a phase III trial. Triple- vs double-agent chemotherapy for advanced non-small-cell lung cancer. Southern Italy Cooperative Oncology Group. Comella, P. Oncology (Williston Park, N.Y.) (2000)
- Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial. Comella, P., De Vita, F., Mancarella, S., De Lucia, L., Biglietto, M., Casaretti, R., Farris, A., Ianniello, G.P., Lorusso, V., Avallone, A., Cartenì, G., Leo, S.S., Catalano, G., De Lena, M., Comella, G. Ann. Oncol. (2000)
- Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group Study. Comella, P., Panza, N., Manzione, L., De Cataldis, G., Cioffi, R., Maiorino, L., Lorusso, V., Lamberti, A., Micillo, E., Natale, M., Bilancia, D., Nicolella, G., Di Nota, A., Mancarella, S., Frasci, G., Comella, G. Clin. Lung. Cancer (2000)
- Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group. Comella, P., Frasci, G., Panza, N., Manzione, L., Lorusso, V., Di Rienzo, G., Cioffi, R., De Cataldis, G., Maiorino, L., Bilancia, D., Nicolella, G., Natale, M., Carpagnano, F., Pacilio, C., De Lena, M., Bianco, A., Comella, G. J. Clin. Oncol. (1999)
